Sputnik Lite: Single-Dose COVID-19 Vaccine To Be Administered In India

The imported COVID-19 Sputnik Lite vaccine shot will cost ₹ 995.40 in India, Dr. Reddy's Laboratories, which is fabricating the vaccine in India, says.

By Harkirpal Singh, Updated : May 14, 2021 18:44 IST
Sputnik Lite: Single-Dose COVID-19 Vaccine To Be Administered In India
image source- indianexpress

Russia's Sputnik Light could be the primary single-dose vaccine to be utilized in India and Dr. Reddy's will hold converses with the government and the controller in June for sure-fire dispatch, revealed NDTV today. Until further notice, the two-dose Sputnik V will be carried out at 35 centers across India. 

The imported vaccine shot will cost ₹ 995.40 in India, Dr. Reddy's Laboratories, which is fabricating the vaccine in India, says. The main dose of the vaccine was administered in Hyderabad today as a component of a delicate dispatch by Dr. Reddy. 

The cost will be cut down once the vaccine is made in India. Sputnik V will be the third vaccine to be utilized in India after Serum Institute of India's Covishield and Bharat Biotech's Covaxin. 

Also Read- COVID-19: India Registers More Than 4000 COVID-19 Deaths For 7 Consecutive Days

Other than the Pfizer and Moderna vaccines, Sputnik V is a direct-injected shot that shows the adequacy of more than 91% against Covid-19 when taken in two doses, 21 days separated. 

The primary part of Sputnik vaccines will be imported from Russia, completely created, and prepared to regulate. At the point when the lack of vaccine shots has eased back down or stopped vaccinations in numerous states, a solitary dose vaccine could be a distinct advantage. 

Should Read- Radicals and Leftists Target Kangana Ranaut Over Her Recent 'Eid Mubarak' Post 

Recently, the government reported that the waiting period between two shots of Covishield ought to be 12 to about four months,  rather than the past four to about a month and a half.  

📣 Follow SeeLatest.com at Twitter, Facebook, Instagram & Telegram. Stay updated for latest headlines.